Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | CONCORD ACQUISI CORP CNDU |
Citadel Advisors LLC | 1,800,094 6.300% |
16 (+0.00%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | L&F Acquisition Corp. LNFA |
Citadel Advisors LLC | 870,009 5.000% |
3,072 (+0.35%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Bull Horn Holdings Corp. BHSE |
Citadel Advisors LLC | 623,209 6.500% |
623,209 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Sutro Biopharma, Inc. STRO |
Citadel Advisors LLC | 1,301,804 2.900% |
-427,172 (-24.71%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Spring Valley Acquisition Corp. SV |
Citadel Advisors LLC | 1,346,600 5.900% |
1,346,600 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Citadel Advisors LLC | 1,503,870 3.700% |
-626,094 (-29.39%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | EdtechX Holdings Acquisition Corp. II EDTXU |
Citadel Advisors LLC | 550,558 4.800% |
460 (+0.08%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Periphas Capital Partnering Corporation PCPC |
Citadel Advisors LLC | 800,752 4.800% |
800,752 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Vincerx Pharma, Inc. VINC |
Citadel Advisors LLC | 31,897 4.500% |
31,897 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | PropTech Investment Corporation II PTIC |
Citadel Advisors LLC | 1,172,713 5.100% |
1,172,713 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Mudrick Capital Acquisition Corporation II MUDS |
Citadel Advisors LLC | 1,480,068 4.700% |
1,480,068 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | Teligent, Inc. TLGT |
Citadel Advisors LLC | 35,583 0.200% |
-167,438 (-82.47%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | 10X CAP VENTURE ACQUISITION CO VCVC |
Citadel Advisors LLC | 1,350,018 6.700% |
1,350,018 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Delwinds Insurance Acquisition Corp. DWIN |
Citadel Advisors LLC | 1,469,268 7.100% |
1,469,268 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Oncorus, Inc. ONCR |
Citadel Advisors LLC | 1,879,337 8.300% |
26,688 (+1.44%) |
Filing History |
| 2021-02-16 4:30 pm Sale |
2020-12-31 | 13G | TREPONT ACQUISITION CORP I TACAU |
Citadel Advisors LLC | 1,231,344 5.400% |
-8,123 (-0.66%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Pine Island Acquisition Corp. PIPP |
Citadel Advisors LLC | 1,498,177 6.900% |
1,498,177 (New Position) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
Citadel Advisors LLC | 2,421,024 7.100% |
7,143 (+0.30%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | MIRAGEN THERAPEUTICS INC MGEN |
Citadel Advisors LLC | 427,218 9.900% |
656 (+0.15%) |
Filing History |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,164,401 7.000% |
218,450 (+7.42%) |
Filing History |